Rice Partnership, LLC Bristol Myers Squibb CO Transaction History

Rice Partnership, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	BUY	$0.13 - $76.84 $380 - $224,987	2,928 New	2,928 $208,000
Q1 2021 May 11, 2021	SELL	$59.34 - $66.74 $191,549 - $215,436	-3,228 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$57.74 - $65.43 $34,644 - $39,258	-600 Reduced 15.67%	3,228 $200,000
Q3 2020 Nov 12, 2020	SELL	$57.43 - $63.64 $223,230 - $247,368	-3,887 Reduced 50.38%	3,828 $231,000
Q2 2020 Aug 13, 2020	SELL	$54.82 - $64.09 $58,986 - $68,960	-1,076 Reduced 12.24%	7,715 $454,000
Q1 2020 May 11, 2020	BUY	$46.4 - $67.43 $11,878 - $17,262	256 Added 3.0%	8,791 $490,000
Q4 2019 Jan 30, 2020	SELL	$49.21 - $64.19 $8,119 - $10,591	-165 Reduced 1.9%	8,535 $548,000
Q3 2019 Nov 07, 2019	SELL	$42.77 - $50.71 $29,254 - $34,685	-684 Reduced 7.29%	8,700 $441,000
Q2 2019 Jul 25, 2019	SELL	$44.62 - $49.34 $37,927 - $41,939	-850 Reduced 8.31%	9,384 $426,000
Q1 2019 May 06, 2019	SELL	$45.12 - $53.8 $76,704 - $91,460	-1,700 Reduced 14.25%	10,234 $488,000
Q4 2018 Jan 22, 2019	SELL	$48.76 - $63.23 $207,230 - $268,727	-4,250 Reduced 26.26%	11,934 $620,000
Q3 2018 Nov 15, 2018	SELL	$55.19 - $62.25 $546,105 - $615,963	-9,895 Reduced 37.94%	16,184 $1.01 Million
Q2 2018 Aug 21, 2018	BUY	$50.53 - $62.98 $24,557 - $30,608	486 Added 1.9%	26,079 $1.44 Million
Q1 2018 May 14, 2018	SELL	$59.92 - $68.98 $542,216 - $624,200	-9,049 Reduced 26.12%	25,593 $1.62 Million
Q4 2017 May 14, 2018	BUY	$59.94 - $65.35 $2.08 Million - $2.26 Million	34,642	34,642 $2.12 Million

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Rice Partnership, LLC, based on Form 13F filings with the SEC.

Stay updated on Rice Partnership, LLC with notifications on news.